Generic name: Methylergonovine Maleate

Pharmacotherapeutic group: Uterine stimulant & Oxytocic

Therapeutic indication: Postpartum and postabortal hemorrhage & Uterine stimulant & Incomplete abortion

Dosage and Administration: Tablet 0.125mg & Injection 0.2mg/1ml

Uterine stimulant:

Adult: Oral, 0.2 to 0.4mg two to four times a day, until the danger of uterine atony and hemorrhage has passed. Generally, a treatment course of 48hr is sufficient. However, in some patient, treatment for to 7 days may be necessary, especially when used for treatment of incomplete abortion.

IM or IV, 0.2mg, repeated in two to four hours if necessary, up to five doses.

Side effect: Bradycardia, coronary vasospasm, allergic reaction, myocardial infarction, nausea, uterine cramping, vomiting, abdominal or stomach pain, diarrhea, dizziness, sweating, tinnitus

Information on the shelf life: Tablet 5years & Injection 2years